{"title": "Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-09-20", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n- Autores\n-\n[P\u00e9rez Lloret, Santiago](/vufind/Author/Home?author=P%C3%A9rez+Lloret%2C+Santiago); [Barrantes, Francisco Jos\u00e9](/vufind/Author/Home?author=Barrantes%2C+Francisco+Jos%C3%A9)\n- A\u00f1o de publicaci\u00f3n\n- 2016\n- Idioma\n- ingl\u00e9s\n- Tipo de recurso\n- art\u00edculo\n- Estado\n- versi\u00f3n publicada\n- Descripci\u00f3n\n- Fil: P\u00e9rez Lloret, Santiago. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; Argentina\nFil: P\u00e9rez Lloret, Santiago. Universidad de Buenos Aires. Facultad de Medicina; Argentina\nFil: Barrantes, Francisco Jos\u00e9. Pontificia Universidad Cat\u00f3lica Argentina. Facultad de Ciencias M\u00e9dicas. Instituto de Investigaciones Biom\u00e9dicas. Laboratorio de Neurobiolog\u00eda Molecular; Argentina\nFil: Barrantes, Francisco Jos\u00e9. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; Argentina\nAbstract: In view of its ability to explain the most frequent motor symptoms of Parkinson\u2019s Disease (PD), degeneration of dopaminergic neurons has been considered one of the disease\u2019s main pathophysiological features. Several studies have shown that neurodegeneration also affects noradrenergic, serotoninergic, cholinergic and other monoaminergic neuronal populations. In this work, the characteristics of cholinergic deficits in PD and their clinical correlates are reviewed. Important neurophysiological processes at the root of several motor and cognitive functions remit to cholinergic neurotransmission at the synaptic, pathway, and circuital levels. The bulk of evidence highlights the link between cholinergic alterations and PD motor symptoms, gait dysfunction, levodopa-induced dyskinesias, cognitive deterioration, psychosis, sleep abnormalities, autonomic dysfunction, and altered olfactory function. The pathophysiology of these symptoms is related to alteration of the cholinergic tone in the striatum and/or to degeneration of cholinergic nuclei, most importantly the nucleus basalis magnocellularis and the pedunculopontine nucleus. Several results suggest the clinical usefulness of antimuscarinic drugs for treating PD motor symptoms and of inhibitors of the enzyme acetylcholinesterase for the treatment of dementia. Data also suggest that these inhibitors and pedunculopontine nucleus deep-brain stimulation might also be effective in preventing falls. Finally, several drugs acting on nicotinic receptors have proved efficacious for treating levodopa-induced dyskinesias and cognitive impairment and as neuroprotective agents in PD animal models. Results in human patients are still lacking.\n- Fuente\n- npj Parkinson's Disease N\u00b0 2, 2016\n- Materia\n-\nMEDICINA\nENFERMEDAD DE PARKINSON\nENFERMEDADES NEUROGENERATIVAS\n- Nivel de accesibilidad\n- acceso abierto\n- Condiciones de uso\n- https://creativecommons.org/licenses/by-nc-sa/4.0/\n- Repositorio\n- Instituci\u00f3n\n- Pontificia Universidad Cat\u00f3lica Argentina\n- OAI Identificador\n- oai:ucacris:123456789/8688\n[Ver los metadatos del registro completo](#collapseDetail)\n|id||\nRIUCA_b47c41bdf3f55c1241da4b61db3d598a\n|\n|oai_identifier_str||\noai:ucacris:123456789/8688\n|\n|network_acronym_str||\nRIUCA\n|\n|repository_id_str||\n2585\n|\n|network_name_str||\nRepositorio Institucional (UCA)\n|\n|spelling||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s diseaseP\u00e9rez Lloret, SantiagoBarrantes, Francisco Jos\u00e9MEDICINAENFERMEDAD DE PARKINSONENFERMEDADES NEUROGENERATIVASFil: P\u00e9rez Lloret, Santiago. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; ArgentinaFil: P\u00e9rez Lloret, Santiago. Universidad de Buenos Aires. Facultad de Medicina; ArgentinaFil: Barrantes, Francisco Jos\u00e9. Pontificia Universidad Cat\u00f3lica Argentina. Facultad de Ciencias M\u00e9dicas. Instituto de Investigaciones Biom\u00e9dicas. Laboratorio de Neurobiolog\u00eda Molecular; ArgentinaFil: Barrantes, Francisco Jos\u00e9. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; ArgentinaAbstract: In view of its ability to explain the most frequent motor symptoms of Parkinson\u2019s Disease (PD), degeneration of dopaminergic neurons has been considered one of the disease\u2019s main pathophysiological features. Several studies have shown that neurodegeneration also affects noradrenergic, serotoninergic, cholinergic and other monoaminergic neuronal populations. In this work, the characteristics of cholinergic deficits in PD and their clinical correlates are reviewed. Important neurophysiological processes at the root of several motor and cognitive functions remit to cholinergic neurotransmission at the synaptic, pathway, and circuital levels. The bulk of evidence highlights the link between cholinergic alterations and PD motor symptoms, gait dysfunction, levodopa-induced dyskinesias, cognitive deterioration, psychosis, sleep abnormalities, autonomic dysfunction, and altered olfactory function. The pathophysiology of these symptoms is related to alteration of the cholinergic tone in the striatum and/or to degeneration of cholinergic nuclei, most importantly the nucleus basalis magnocellularis and the pedunculopontine nucleus. Several results suggest the clinical usefulness of antimuscarinic drugs for treating PD motor symptoms and of inhibitors of the enzyme acetylcholinesterase for the treatment of dementia. Data also suggest that these inhibitors and pedunculopontine nucleus deep-brain stimulation might also be effective in preventing falls. Finally, several drugs acting on nicotinic receptors have proved efficacious for treating levodopa-induced dyskinesias and cognitive impairment and as neuroprotective agents in PD animal models. Results in human patients are still lacking.Parkinson's Disease FoundationMacmillan Publishers Limited2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttps://repositorio.uca.edu.ar/handle/123456789/86882373-8057 (online)10.1038/npjparkd.2016.1P\u00e9rez Lloret S, Barrantes FJ. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease. npj Parkinson's Disease 2,16001; doi: 10.1038/npjparkd.2016.1 (2016). Disponible en: https://repositorio.uca.edu.ar/handle/123456789/8688npj Parkinson's Disease N\u00b0 2, 2016reponame:Repositorio Institucional (UCA)instname:Pontificia Universidad Cat\u00f3lica Argentinainstacron:UCAenginfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/2023-09-20T11:29:04Zoai:ucacris:123456789/8688Institucionalhttps://repositorio.uca.edu.ar/Universidad privadaNo correspondehttps://repositorio.uca.edu.ar/oaiclaudia_fernandez@uca.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:25852023-09-20 11:29:06.616Repositorio Institucional (UCA) - Pontificia Universidad Cat\u00f3lica Argentinafalse\n|\n|dc.title.none.fl_str_mv||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|title||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|spellingShingle||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\nP\u00e9rez Lloret, Santiago\nMEDICINA\nENFERMEDAD DE PARKINSON\nENFERMEDADES NEUROGENERATIVAS\n|title_short||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|title_full||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|title_fullStr||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|title_full_unstemmed||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|title_sort||\nDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease\n|\n|dc.creator.none.fl_str_mv||\nP\u00e9rez Lloret, Santiago\n|\nBarrantes, Francisco Jos\u00e9\n|author||\nP\u00e9rez Lloret, Santiago\n|\n|author_facet||\nP\u00e9rez Lloret, Santiago\n|\nBarrantes, Francisco Jos\u00e9\n|author_role||\nauthor\n|\n|author2||\nBarrantes, Francisco Jos\u00e9\n|\n|author2_role||\nauthor\n|\n|dc.subject.none.fl_str_mv||\nMEDICINA\n|\nENFERMEDAD DE PARKINSON\nENFERMEDADES NEUROGENERATIVAS\n|topic||\nMEDICINA\n|\nENFERMEDAD DE PARKINSON\nENFERMEDADES NEUROGENERATIVAS\n|dc.description.none.fl_txt_mv||\nFil: P\u00e9rez Lloret, Santiago. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; Argentina\n|\nFil: P\u00e9rez Lloret, Santiago. Universidad de Buenos Aires. Facultad de Medicina; Argentina\nFil: Barrantes, Francisco Jos\u00e9. Pontificia Universidad Cat\u00f3lica Argentina. Facultad de Ciencias M\u00e9dicas. Instituto de Investigaciones Biom\u00e9dicas. Laboratorio de Neurobiolog\u00eda Molecular; Argentina\nFil: Barrantes, Francisco Jos\u00e9. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; Argentina\nAbstract: In view of its ability to explain the most frequent motor symptoms of Parkinson\u2019s Disease (PD), degeneration of dopaminergic neurons has been considered one of the disease\u2019s main pathophysiological features. Several studies have shown that neurodegeneration also affects noradrenergic, serotoninergic, cholinergic and other monoaminergic neuronal populations. In this work, the characteristics of cholinergic deficits in PD and their clinical correlates are reviewed. Important neurophysiological processes at the root of several motor and cognitive functions remit to cholinergic neurotransmission at the synaptic, pathway, and circuital levels. The bulk of evidence highlights the link between cholinergic alterations and PD motor symptoms, gait dysfunction, levodopa-induced dyskinesias, cognitive deterioration, psychosis, sleep abnormalities, autonomic dysfunction, and altered olfactory function. The pathophysiology of these symptoms is related to alteration of the cholinergic tone in the striatum and/or to degeneration of cholinergic nuclei, most importantly the nucleus basalis magnocellularis and the pedunculopontine nucleus. Several results suggest the clinical usefulness of antimuscarinic drugs for treating PD motor symptoms and of inhibitors of the enzyme acetylcholinesterase for the treatment of dementia. Data also suggest that these inhibitors and pedunculopontine nucleus deep-brain stimulation might also be effective in preventing falls. Finally, several drugs acting on nicotinic receptors have proved efficacious for treating levodopa-induced dyskinesias and cognitive impairment and as neuroprotective agents in PD animal models. Results in human patients are still lacking.\n|description||\nFil: P\u00e9rez Lloret, Santiago. Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas; Argentina\n|\n|publishDate||\n2016\n|\n|dc.date.none.fl_str_mv||\n2016\n|\n|dc.type.none.fl_str_mv||\ninfo:eu-repo/semantics/article\n|\ninfo:eu-repo/semantics/publishedVersion\nhttp://purl.org/coar/resource_type/c_6501\ninfo:ar-repo/semantics/articulo\n|format||\narticle\n|\n|status_str||\npublishedVersion\n|\n|dc.identifier.none.fl_str_mv||\nhttps://repositorio.uca.edu.ar/handle/123456789/8688\n|\n2373-8057 (online)\n10.1038/npjparkd.2016.1\nP\u00e9rez Lloret S, Barrantes FJ. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease. npj Parkinson's Disease 2,16001; doi: 10.1038/npjparkd.2016.1 (2016). Disponible en: https://repositorio.uca.edu.ar/handle/123456789/8688\n|url||\nhttps://repositorio.uca.edu.ar/handle/123456789/8688\n|\n|identifier_str_mv||\n2373-8057 (online)\n|\n10.1038/npjparkd.2016.1\nP\u00e9rez Lloret S, Barrantes FJ. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease. npj Parkinson's Disease 2,16001; doi: 10.1038/npjparkd.2016.1 (2016). Disponible en: https://repositorio.uca.edu.ar/handle/123456789/8688\n|dc.language.none.fl_str_mv||\neng\n|\n|language||\neng\n|\n|dc.rights.none.fl_str_mv||\ninfo:eu-repo/semantics/openAccess\n|\nhttps://creativecommons.org/licenses/by-nc-sa/4.0/\n|eu_rights_str_mv||\nopenAccess\n|\n|rights_invalid_str_mv||\nhttps://creativecommons.org/licenses/by-nc-sa/4.0/\n|\n|dc.format.none.fl_str_mv||\napplication/pdf\n|\n|dc.publisher.none.fl_str_mv||\nParkinson's Disease Foundation\n|\nMacmillan Publishers Limited\n|publisher.none.fl_str_mv||\nParkinson's Disease Foundation\n|\nMacmillan Publishers Limited\n|dc.source.none.fl_str_mv||\nnpj Parkinson's Disease N\u00b0 2, 2016\n|\nreponame:Repositorio Institucional (UCA)\ninstname:Pontificia Universidad Cat\u00f3lica Argentina\ninstacron:UCA\n|reponame_str||\nRepositorio Institucional (UCA)\n|\n|collection||\nRepositorio Institucional (UCA)\n|\n|instname_str||\nPontificia Universidad Cat\u00f3lica Argentina\n|\n|instacron_str||\nUCA\n|\n|institution||\nUCA\n|\n|repository.name.fl_str_mv||\nRepositorio Institucional (UCA) - Pontificia Universidad Cat\u00f3lica Argentina\n|\n|repository.mail.fl_str_mv||\nclaudia_fernandez@uca.edu.ar\n|\n|_version_||\n1777570019804184576\n|\n|score||\n12.888536\n|", "language": null, "image": null, "pagetype": null, "links": ["#content", "http://www.argentina.gob.ar/", "https://www.argentina.gob.ar", "https://www.argentina.gob.ar/ciencia", "/vufind/", "/vufind/Search/Advanced", "/vufind/", "/vufind/Record/RIUCA_b47c41bdf3f55c1241da4b61db3d598a/Cite", "/vufind/Record/RIUCA_b47c41bdf3f55c1241da4b61db3d598a/Export", "/vufind/Record/RIUCA_b47c41bdf3f55c1241da4b61db3d598a/Export?style=RefWorks", "/vufind/Record/RIUCA_b47c41bdf3f55c1241da4b61db3d598a/Export?style=EndNoteWeb", "/vufind/Record/RIUCA_b47c41bdf3f55c1241da4b61db3d598a/Export?style=EndNote", "#", "/vufind/Author/Home?author=P%C3%A9rez+Lloret%2C+Santiago", "/vufind/Author/Home?author=Barrantes%2C+Francisco+Jos%C3%A9", "https://repositorio.uca.edu.ar/handle/123456789/8688", "#collapseDetail", "/vufind/Record/RIUCA_0b0f8db1342c5371ac85a1a43fdb4d42", "/vufind/Record/RIUCA_b5c33442405717d8e78d138e09bd5997", "/vufind/Record/RIUCA_f796c59c2d66e59dbe7b62c49616927c", "/vufind/Record/RIUCA_8edeb5cf4a360a9c7593f002136a983f", "/vufind/Record/RIUCA_3cf134a4836fc601982425e6c703f9be", "https://www.argentina.gob.ar/turnos", "https://www.argentina.gob.ar/jefatura/innovacion-publica/administrativa/tramites-a-distancia", "https://www.argentina.gob.ar/miargentina/mesadeayuda", "https://www.argentina.gob.ar/pais", "https://www.argentina.gob.ar/normativa", "https://www.argentina.gob.ar/organismos", "https://www.argentina.gob.ar/jefatura/mapa-del-estado", "https://www.argentina.gob.ar/acerca", "https://www.argentina.gob.ar/terminos-y-condiciones", "https://www.argentina.gob.ar/sugerencias"]}